Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers

Transplantation

Volumn 78, Issue 1, 2004, Pages 31-40

  Schilbach, Karin ^a,b   Schick, Judith ^a   Fluhr, Herbert ^a   Marquordt, Katja ^a   Wehrmann, Manfred ^b   Schütt, Burkhardt S ^a   Schlegel, Paul G ^a   Niethammer, Dietrich ^a   Eyrich, Matthias ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CLONE; COMPLEMENTARITY DETERMINING REGION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAFT VERSUS HOST REACTION; HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SAFETY; T LYMPHOCYTE ACTIVATION; TARGET ORGAN; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; BONE MARROW TRANSPLANTATION; COLON; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; ILEUM; LIVER; MICE; MICE, INBRED BALB C; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; ORGAN SPECIFICITY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN; SPLEEN;

EID: 4143087246     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000133510.47573.97     Document Type: Article

References (30)

1. Pion S, Fontaine P, Baron C, et al. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy. J Clin Invest 1995; 95(4): 1561.
2. Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19(16): 3685.
3. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18(4): 295.
4. Wallny HJ, Rammensee HG. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990; 343(6255): 275.
5. Miconnet I, Roger T, Seman M, et al. Critical role of endogenous Mtv in acute lethal graft-versus-host disease. Eur J Immunol 1995; 25(2): 364.
6. Perreault C, Jutras J, Roy DC, et al. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest 1996; 98(3): 622.
7. Warren EH, Greenberg PD, Riddell SR. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 1998; 91(6): 2197.
8. Howell CD, De Victor D, Li J, et al. Liver T cell subsets and adhesion molecules in murine graft-versus-host disease. Bone Marrow Transplant 1995; 16(1): 139.
9. Chen W, Howell CD. Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease. Hepatology 2002; 35(1): 23.
10. Margolis DA, Casper JT, Segura AD, et al. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant 2000; 6(4): 408.
11. Friedman TM, Station D, Jones SC, et al. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate. Biol Blood Marrow Transplant 2001; 7(1): 2.
12. Schlegel PG, Vaysburd M, Chen Y, et al. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers. J Immunol 1995; 155(8): 3856.
13. Schlegel PG, Aharoni R, Chen Y, et al. A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo. Proc Natl Acad Sci U S A 1996; 93(10): 5061.
14. Johnston SL, Wettstein PJ. Spectratyping of TCR expressed by CTL-infiltrating male antigen (HY)-disparate allografts. J Immunol 1998; 160(7): 3374.
15. Berschick P, Fehsel K, Weltzien HU, et al. Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice. J Autoimmun 1993; 6(4): 405.
16. Korngold R, Sprent J. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 1987; 165(6): 1552.
17. Korngold R. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses. Bone Marrow Transplant 1992; 9(5): 355.
18. Dong C, Winters GL, Wilson JE, et al. Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts. Am J Pathol 1997; 151 (1): 121.
19. Blazar BR, Taylor PA, Snover DC, et al. Nonmitogenic anti-CD3F(ab′) 2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier. J Immunol 1993; 150(1): 265.
20. Gilman AL, Kooy NW, Atkins DL, et al. Complete heart block in association with graft-versus-host disease. Bone Marrow Transplant 1998; 21(1): 85.
21. Platzbecker U, Klingel K, Thiede C, et al. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 2001; 27(1): 107.
22. Seko Y, Takahashi N, Ishiyama S, et al. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 1998; 97(7): 637.
23. New JY, Li B, Koh WP, et al. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease. Bone Marrow Transplant 2002; 29(12): 979.
24. Goulvestre C, Batteux F, Charreire J. Chemokines modulate experimental autoimmune thyroiditis through attraction of autoreactive or regulatory T cells. Eur J Immunol 2002; 32(12): 3435.
25. Ghaznawie M, Papadimitriou JM, Heenan PJ. The steady-state turnover of murine epidermal Langerhans cells. Br J Dermatol 1999; 141(1): 57.
26. Cole S, Townsend KM. Dose response of Langerhans cells in mouse footpad epidermis after X irradiation. Radiat Res 1985; 103(2): 251.
27. Fasso M, Anandasabapathy N, Crawford F, et al. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. J Exp Med 2000; 192(12): 1719.
28. Hebib NC, Deas O, Rouleau M, et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. Blood 1999; 94(5): 1803.
29. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16(4): 176.
30. Johnston SL, Wettstein PJ. T cell receptor diversity in CTLs specific for the CTT-1 and CTT-2 minor histocompatibility antigens. J Immunol 1997; 159(6): 2606.